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Preface
Streptococcus pneumoniae is an invasive, sterile-site pathogen accounting for approximately 
1500 notifications annually in Australia. This number however underestimates its clinical 
impact, as it does not include ear or eye infections, or pneumonias unaccompanied by 
septicaemia. Its interaction with humans involves asymptomatic colonization, especially of 
children, and this may serve as a prelude to invasive disease. This study examined 
colonization by pneumococci and other potentially clinically significant bacteria in children 
presenting with acute respiratory infections. It was found that children are very commonly 
colonized with bacteria which are capable of clinical disease. Similarly, they frequently carry 
"paediatric strains" of pneumococci which can exhibit antibiotic resistance and are capable of 
invasive disease. Children are therefore the likely reservoir for pneumococci, and an 
important factor in the epidemiology of the pneumococcus. This organism is now actively 
vaccinated against in Australia, and this is likely to both inhibit colonization by vaccine 
strains, and possibly select for serotype replacement strains. This study represents a "snap­
shot" of capsular strains colonizing children prior to the introduction of universal 
pneumococcal vaccination in Australia, what antibiotic resistance they possessed, and 
whether their acquisition is influenced by respiratory viral infection.
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Abstract
Pneumococcal disease involves infections at both sterile and non-sterile sites, and accounts 
for considerable morbidity and mortality in Australia. Its public health significance has 
prompted the progressive introduction of vaccination against the most clinically significant 
capsular serotypes. Initially, vaccination involved those at greatest risk, such as indigenous 
Australians and those with chronic diseases and other underlying risk factors. More recently, 
universal vaccination was introduced for children, using immunogenic protein-conjugated 
capsular polysaccharide antigens of the most common invasive paediatric pneumococcal 
strains.
Vaccination is protective against invasive disease, but also introduces selection pressures 
against those vaccine strains. This will likely alter colonization dynamics, with perhaps 
serotype replacement or the emergence of vaccine escape mutants. Evidence to date suggests 
that vaccine serotypes have been partially displaced, and that some non-vaccine strains, such 
as 19A, are increasingly associated with invasive disease.
This study sought to establish the state of colonization by pneumococci, and other potential 
bacterial pathogens in children prior to the introduction of the universal 7-valent conjugated 
capsular polysaccharide vaccine in 2005. Children represent the reservoir for pneumococci in 
the community, and are known to harbour antibiotic-resistant strains. This study helps 
establish a colonization baseline, which may assist in detecting changes in colonization 
attributable to universal vaccination. The study also sought correlates between bacterial 
nasopharyngeal colonization, and viral respiratory infection. It has long been thought that 
viral respiratory infections predispose for invasive pneumococcal disease, possibly because of
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co-acquisition of both virus and the bacterium in respiratory droplets, with the viral infection 
then producing mucosal inflammation and injury conducive to bacterial invasion.
During 2004 and 2005, 495 nasopharyngeal aspirate specimens (NPA) for children up to 5 
years of age presenting with acute respiratory infections were tested. These represented those 
eligible for study inclusion, and did not include those excluded on the basis of age, extended 
time as an inpatient, or repeat collections. NPA sampling was conducted over a total of 18 
months, but specimens were most frequently collected during winter and early spring in 2004 
and 2005. For analysis, the participants were broken into age groups to allow comparison 
with previous studies. Participants comprised 130 children aged less than 6 months, 256 aged 
6 months to less than 2 years, and 109 aged 2 to 5 years.
Bacterial colonization was common, with 79% of specimens growing either Streptococcus 
pneumoniae, Staphylococcus aureus, Haemophilus influenzae or Moraxella catarrhalis. Co­
colonization was common. H. influenzae isolates were non-typeable. S. pneumoniae was 
present in 33% of specimens combined for age and gender, with H. influenzae similar (34%), 
followed by S. aureus (25%) and M. catarrhalis (37%). Three percent of children were 
colonized with methicillin-resistant S. aureus. S. pneumoniae isolates were typed for their 
capsular polysaccharide antigens by both established serological techniques using antisera 
from the Statens Serum Institut, Denmark, and by a multiplex PCR reverse line blot assay 
(mPCR/RLB). These 2 techniques showed very good agreement, and showed that 63% of 
pneumococcal isolates for all ages were vaccine strains covered by the 7-valent protein- 
conjugated capsular polysaccharide vaccine (4, 6B, 9V, 14, 18C, 19F and 23F). The most 
commonly isolated vaccine strains were 19F (49% of total), 23F (14%), 6B and 14 (both 13% 
of total). The most common non-vaccine strains were 6A (17% of total) and 19A (9%). 
Generally a single pneumococcal serotype alone was recovered - only 1 specimen yielded 2
capsular serotypes.
Antibiotic susceptibility was determined for S. pneumoniae isolates by E-test and disc 
diffusion methods, and interpreted to Clinical and Laboratory Standards Institute (CLSI) 
guidelines. Penicillin non-susceptibility was detected in 40% of pneumococci isolates for all 
ages combined. Penicillin non-susceptibility amongst the more commonly isolated 7-valent 
vaccine serotypes ranged from 90% of 9V isolates, to 15% of 6B isolates. Of the frequently 
isolated non-vaccine serotypes, penicillin non-susceptibility was detected in 67% of 19A 
isolates, and 18% of 6A isolates. Ceftriaxone non-susceptibility was present in 18% of all S. 
pneumoniae isolates, for all ages combined. Erythromycin non-susceptibility was found in 
33% of total isolates, and clindamycin non-susceptibility in 20%.
NPA specimens were tested by immunofluoresence for the presence of respiratory syncytial 
virus (RSV), influenza A and B, parainfluenza viruses 1,2 and 3, and adenovirus. Specimens 
were also cultured to detect less common viruses not covered by immunofluorescence, but 
human metapneumovirus and coronaviruses were not detectable in the study. A single virus 
was detected in 54% of all specimens - no specimen yielded more than 1 virus. RSV was 
most frequently found (148 in total, representing 57% of all viruses). Rhinoviruses were the 
next most frequent (16.1%) followed by adenoviruses (11.5%), influenza A (7.3%), 
parainfluenza 3 (4.2%), parainfluenza 1 (2.3%), echovirus (1.1%) and enteroviruses (0.8%). 
Only one specimen tested positive for influenza B.
Statistical tests for association between respiratory viruses and the presence of colonizing 
bacteria gave mixed results. Chi-squared testing indicated an association between the 
presence of S. pneumoniae for all ages combined, and RSV detection (p = 0.03). This 
however only held for children in the age range of 6 months to less than 2 years (p = 0.038), 
and not for those aged less than 6 months, or those 2 years to 5 years. H. influenzae was 
significantly associated with the detection of any virus in the NPA. No other significant
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association between bacteria and viruses were detected by the Chi-squared test. Multiple 
logistic regression analysis however did not indicate any contribution by RSV to the presence 
of nasopharyngeal S. pneumoniae. In contrast, a significant contribution by H. influenzae and 
M. catarrhalis was found (p values 0.02 and 0.014 respectively). No other associations 
approached significance.
This study confirms previous findings that children have high rates of nasopharyngeal 
colonization with S. pneumoniae and other potentially pathogenic bacteria. The capsular 
strains of pneumococci isolated are largely identical to those reported in childhood 
colonization studies from Europe and the USA. Other strains are less frequent colonizers. 
Coverage of the strains isolated by the current paediatric vaccine only extends to 
approximately 63%. Of potential concern is the presence of serotype 19A, a strain which has 
been more frequently isolated in invasive disease overseas in the post-vaccine era. Antibiotic 
resistance was quite common in the pneumococci isolated. Viral respiratory infection was 
commonly superimposed on pneumococcal colonization, although the statistics were 
discordant on the strength of association. The study establishes a snapshot of the 
colonization, and antimicrobial resistance present in a population at the commencement of 
universal vaccination. Vaccination perturbs pneumococcal colonization biology, so the 
potential now exists for strain displacement and vaccine-escape variants to become more 
frequent colonizers, and possibly more commonly invasive and clinically significant. The 
study details a reverse line blot (RLB) method to better track colonizers, and provides the 
colonization baseline against which changes may be compared.
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